TrialPharmacological research2018

Phase IIa trial in Duchenne muscular dystrophy shows vamorolone is a first-in-class dissociative steroidal anti-inflammatory drug.

Laurie S Conklin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.